Search company, investor...
Search

Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

7

About Friedman BioVenture

Friedman Bioventure aims to identify, vet and manage investments and portfolio companies in biomedical arena.

Friedman BioVenture Headquarters Location

San Diego, California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Friedman BioVenture News

PetDx Completes $62M Series B Round

Dec 10, 2021

PetDx today announced the completion of its Series B financing with over $62 million in new capital raised, which is one of the biggest Series B rounds for a pet startup; bringing the company's total funding to date to $72 million. The financing was led by Longview Asset Management with participation by Declaration Partners, Torch Capital, Aperture Venture Partners, Valor Equity Partners, Friedman Bioventure, K4 Family Investments, and Labcorp (NYSE:LH). The company's $10M Series A financing in August 2020 was led by Friedman Bioventure with participation from Petco (Nasdaq:WOOF) and an undisclosed leading pet healthcare company. PetDx® - The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Friedman BioVenture Investments

7 Investments

Friedman BioVenture has made 7 investments. Their latest investment was in PetDx as part of their Series B on August 8, 2021.

CBI Logo

Friedman BioVenture Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/30/2021

Series B

PetDx

$62M

No

7

3/1/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

9/15/2020

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

8/12/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

9/20/2019

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/30/2021

3/1/2021

9/15/2020

8/12/2020

9/20/2019

Round

Series B

Series B

Series C - II

Series A

Series A - II

Company

PetDx

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$62M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

10

10

10

10

Friedman BioVenture Team

1 Team Member

Friedman BioVenture has 1 team member, including current Managing Partner, Jeffrey Friedman.

Name

Work History

Title

Status

Jeffrey Friedman

Managing Partner

Current

Name

Jeffrey Friedman

Work History

Title

Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.